4.8 Review

Inflammasomes in liver diseases

Journal

JOURNAL OF HEPATOLOGY
Volume 57, Issue 3, Pages 642-654

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2012.03.035

Keywords

Inflammasomes; Interleukin-1 beta; Caspase-1; Drug induced liver injury; Ischaemiareperfusion; Endotoxin; Steatohepatitis; Viral hepatitis; Fibrosis

Ask authors/readers for more resources

Inflammation is a common element in the pathogenesis of most chronic liver diseases that lead to fibrosis and cirrhosis. Inflammation is characterized by activation of innate immune cells and production of pro-inflammatory cytokines IL-1 alpha, IL-1 beta, and TNF alpha. Inflammasomes are intracellular multiprotein complexes expressed in both parenchymal and non-parenchymal cells of the liver that in response to cellular danger signals activate caspase-1, and release IL-1 beta and IL-18. The importance of inflamma-some activation in various forms of liver diseases in relation to liver damage, steatosis, inflammation and fibrosis is discussed in this review. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available